Abstract:Background and purpose Previous studies have shown that the mean dose to the parotid gland stem cell rich regions (D mean,SCR ) is the strongest dosimetric predictor for the risk of patient-reported daytime xerostomia. This study aimed to test whether the relationship between patient-reported xerostomia and D mean,SCR is explained by a dose-dependent reduction of saliva production. Material/methods In 570 head and neck cancer patients treated with definitive radiation therapy (RT), flow from the parotid (FLOW PAR ) and submandibular/sublingual glands (FLOW SMSL ) and patient-reported daytime (XER DAY ) and nighttime xerostomia (XER NIGHT ) were prospectively measured before, and at 6 and 12 months after RT. Using linear mixed effect models, the relations of mean dose to the parotid glands (D mean,par ), D mean,SCR , non-SCR parotid gland tissue (D mean,non-SCR ), submandibular glands (D mean,sub ) and oral cavity (D mean,oral ) with salivary flow and xerostomia were analyzed while correcting for known confounders. Results D mean,SCR proved to be responsible for the effect of D mean,par on FLOW PAR (p≤0.03), while D mean,non-SCR did not affect FLOW PAR (p≥0.11). To illustrate, increasing D mean,SCR by 10 Gy at fixed D mean,non-SCR , reduced FLOW PAR by 0.02 (25%) after RT. However, if the opposite happened, no change in FLOW PAR was observed (0.00 ml/min [4%]). As expected, D mean,sub was significantly associated with FLOW SMSL (p<0.001). For example, increasing D mean,sub by 10 Gy, reduced FLOW SMSL with 0.07 ml/min (26%) after RT. Xerostomia scores were also affected by dose to the salivary glands. D mean,SCR and D mean,oral were associated with higher XER DAY scores (p≤0.05), while D mean,sub increased XER NIGHT scores (p=0.01). For example, an increase of 10 Gy in D mean,SCR raised XER DAY scores with 2.13 (5%) points after RT, while an additional 10 Gy in D mean,subs increased XER NIGHT scores with 2.20 points (6%) after RT. Salivary flow was not only associated with radiation dose, but also with xerostomia scores in line with the salivary glands' functions, i.e., FLOW PAR only influenced XER DAY (p<0.001, 10.92 points lower XER DAY per 1 ml/min saliva), while FLOW SMSL affected XER DAY and XER NIGHT (p≤0.004, 6.69 and 5.74 points lower XER DAY and XER NIGHT , respectively, per 1 ml/min saliva). Therefore, the observed relations between dose and xerostomia were corrected for salivary flow. As hypothesized, D mean,SCR only increased XER DAY scores via reducing FLOW PAR ; whereas the effects of D mean,oral on XER DAY and of D mean,sub on XER NIGHT were independent of salivary flow. Conclusion Higher SCR region dose reduced parotid gland saliva production, subsequently resulting in higher daytime xerostomia scores. Consequently, this study supports the clinical implementation of stem cell sparing RT to preserve salivary flow with the aim of reducing the risk of xerostomia.

Efficacy of Office-Based Salivary Ductal Steroid Irrigation for Managing Post-Irradiation Xerostomia in Head and Neck Cancer Patients: A Retrospective Study

Oncological Outcome of Patients with Salivary Gland Cancer Treated with Surgery and Postoperative Intensity-Modulated Radiotherapy: a Retrospective Study

Diagnosis, Prevention, and Treatment of Radiotherapy-Induced Xerostomia: A Review

Effects of an integrated supportive program on xerostomia and saliva characteristics in patients with head and neck cancer radiated with a low dose to the major salivary glands: a randomized controlled trial

Impact on xerostomia for patients with nasopharyngeal carcinoma treated with superficial parotid lobe-sparing intensity-modulated radiation therapy (SPLS-IMRT): A prospective phase II randomized controlled study.

Mesenchymal Stem/Stromal Cell Therapy for Radiation-Induced Xerostomia in Previous Head and Neck Cancer Patients: A Phase 2 Randomised, Placebo-Controlled Trial

Salivary gland function in nasopharyngeal carcinoma before and late after intensity-modulated radiotherapy evaluated by dynamic diffusion-weighted MR imaging with gustatory stimulation

Mesenchymal Stem/Stromal Cell Therapy for Radiation-Induced Xerostomia in Previous Head and Neck Cancer Patients: A Phase II Randomized, Placebo-Controlled Trial

Magnetic Resonance Sialography for Investigating Major Salivary Gland Duct System after Intensity-Modulated Radiotherapy of Nasopharyngeal Carcinoma

Survey on Xerostomia after radiotherapy for the nasopharyngeal carcinoing patients

Effect of dose to parotid ducts on Sticky Saliva and Xerostomia in radiotherapy of head and neck squamous cell carcinoma

Radiation-Induced Xerostomia in Patients with Head and Neck Cancer Treated with Comprehensive Salivary Gland-Sparing Helical Tomotherapy Technique: Based on a Backpropagation Artificial Neural Network

The Preventive and Therapeutic Effect of Acupuncture for Radiation-Induced Xerostomia in Patients with Head and Neck Cancer

Evaluation of Salivary Gland Function Using Diffusion-Weighted Magnetic Resonance Imaging for Follow-Up of Radiation-Induced Xerostomia

Dosimetry of Submandibular Glands on Xerostomia for Nasopharyngeal Carcinoma

Magnetic Resonance Sialography to Evaluate Radiation-Induced Xerostomia in Patients with Early-Stage Nasopharyngeal Carcinoma

Randomized Double-Blind Placebo-Controlled Study of Salivary Substitute with Enzymatic System for Xerostomia in Patients Irradiated in Head and Neck Region

Effects of herbal medicine for xerostomia in head and neck cancer patients: an observational study in a tertiary cancer hospital

Prospective phase II study of the efficacy of transcutaneous electrical nerve stimulation in post-radiation patients

Radiation-induced xerostomia is related to stem cell dose-dependent reduction of saliva production

A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact